Product Program year 2025 Source: CMS Open Payments

Disposable Biopsy Forceps

Device EndoTherapy

PDI 04953170354120

Open in the dashboard

General payments

$575,396

274 payments

Research payments

$0

0 payments

Through program year 2025, $575,396 in general payments and $0 in research payments were reported against Disposable Biopsy Forceps (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $107,904 129
2024 General $209,467 46
2023 General $122,126 40
2022 General $48,834 39
2021 General $87,065 20

Breakdown

Who paid General payments · program years 2021–2025
  1. Olympus Corporation of the Americas $435,612 45 payments
  2. Olympus America Inc. $139,785 229 payments
Top recipients General payments · program year 2025
  1. Uci Medical Center Teaching hospital · CA $29,918 28% · 1 payment
  2. Henry Ford Hospital Teaching hospital · MI $24,189 22% · 1 payment
  3. Sanjiv Khetarpal Gastroenterology · Canton, OH $11,858 11% · 1 payment
  4. Jennifer Davids Colon & Rectal Surgery · Boston, MA $9,360 9% · 9 payments
  5. Olga Beresneva Colon & Rectal Surgery · Boston, MA $7,746 7% · 9 payments

The top 5 of 85 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $30,033 62% · 43 practitioners
  2. Colon & Rectal Surgery $17,149 35% · 4 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $363 <1% · 4 practitioners
  4. Internal Medicine $353 <1% · 6 practitioners
  5. Nurse Practitioner $188 <1% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $30,022 28% · 6 recipients
  2. Michigan $24,377 23% · 2 recipients
  3. Massachusetts $24,135 22% · 7 recipients
  4. Ohio $11,997 11% · 8 recipients
  5. Texas $5,831 5% · 27 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

274 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record